3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
6
Leukemia, Myelomonocytic, Chronic
3
Neoplasms
2
Myeloproliferative Disorders
2
Hodgkin Disease
2
GATA2 Deficiency
2
Anemia, Refractory, with Excess of Blasts
2
Pathologic Complete Response
1
Neoplasm Metastasis
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
11
fludarabine
6
Vincristine
4
Rituximab
4
Doxorubicin
4
zanubrutinib
3
Prednisone
3
pirtobrutinib
2
cemiplimab
2
acalabrutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Dexamethasone
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
X-Rays
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Azacitidine
×
30 days
×
Clear all
No trials found.